Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies
Multiple Sclerosis International · 2011
DOI: 10.1155/2011/246412 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Multiple Sclerosis International, 2011. Verfasst von Charlotte E Teunissen und 27 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Chemistry, Neurological Laboratory and Biobank, VU University Medical Center, FdG, P.O. Box 7057, 1007 MB Amsterdam, The Nethe…. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
There is a long history of research into body fluid biomarkers in neurodegenerative and neuroinflammatory diseases. However, only a few biomarkers in cerebrospinal fluid (CSF) are being used in clinical practice. Anti-aquaporin-4 antibodies in serum are currently useful for the diagnosis of neuromyelitis optica (NMO), but we could expect novel CSF biomarkers that help define prognosis and response to treatment for this disease. One of the most critical factors in biomarker research is the inadequate powering of studies performed by single centers. Collaboration between investigators is needed to establish large biobanks of well-defined samples. A key issue in collaboration is to establish standardized protocols for biobanking to ensure that the statistical power gained by increasing the numbers of CSF samples is not compromised by pre-analytical factors. Here, consensus guidelines for CSF collection and biobanking are presented, based on the guidelines that have been published by the BioMS-eu network for CSF biomarker research. We focussed on CSF collection procedures, pre-analytical factors and high quality clinical and paraclinical information. Importantly, the biobanking protocols are applicable for CSF biobanks for research targeting any neurological disease.
Autor:innen und Institutionen
- Department of Clinical Chemistry, Neurological Laboratory and Biobank, VU University Medical Center, FdG, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands.
Zitieren
APA
Teunissen, C. E., Tumani, H., Bennett, J. L., Berven, F. S., Brundin, L., Comabella, M., Franciotta, D., Federiksen, J. L., Fleming, J. O., Furlan, R., Hintzen, R. Q., Hughes, S. G., Jimenez, C. R., Johnson, M. H., Killestein, J., Krasulova, E., Kuhle, J., Magnone, M. C., Petzold, A., …, & Hemmer, B. (2011). Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies. Multiple Sclerosis International. https://doi.org/10.1155/2011/246412
Vancouver
Teunissen CE, Tumani H, Bennett JL, Berven FS, Brundin L, Comabella M, et al. Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies. Multiple Sclerosis International. 2011. doi:10.1155/2011/246412
BibTeX
@article{Teunissen2011,
author = {Teunissen, Charlotte E and Tumani, Hayrettin and Bennett, Jeffrey L and Berven, Frode S and Brundin, Lou and Comabella, Manuel and Franciotta, Diego and Federiksen, Jette L and Fleming, John O and Furlan, Roberto and Hintzen, Rogier Q and Hughes, Steve G and Jimenez, Connie R and Johnson, Michael H and Killestein, Joep and Krasulova, Eva and Kuhle, Jens and Magnone, Maria-Chiara and Petzold, Axel and Rajda, Cecilia and Rejdak, Konrad and Schmidt, Hollie K and van Pesch, Vincent and Waubant, Emmanuelle and Wolf, Christian and Deisenhammer, Florian and Giovannoni, Gavin and Hemmer, Bernhard},
title = {Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies},
journal = {Multiple Sclerosis International},
year = {2011},
doi = {10.1155/2011/246412}
}
EUVIMED